Gelonghui, May 10 | Novavax Pharmaceuticals (NVAX.US) rose 146.09% to US$11 in early trading. It was the largest increase since 2009.
In terms of news, Novavax Pharmaceuticals announced mixed Q1 results on Friday. At the same time, the company reached a cooperation agreement with French pharmaceutical giant Sanofi (SNY.US) worth up to US$1.2 billion. Promote the commercialization of COVID-19 vaccines and the development of combination vaccines. And lifted the previously issued continuing operation warning.
Novavax surges 146%, reaches $1.2 billion cooperation agreement with Sanofi
Gelonghui, May 10 | Novavax Pharmaceuticals (NVAX.US) rose 146.09% to $11 in early trading, the largest increase since 2009
Like (0)
U.S. semiconductor sector stocks strengthen
Previous
May 10, 2024 10:32 pm
U.S. multinationals also become victims as the strong dollar wields its sickle
Next
May 10, 2024 10:32 pm